These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24736308)

  • 1. Uncovering the role of the insula in non-motor symptoms of Parkinson's disease.
    Christopher L; Koshimori Y; Lang AE; Criaud M; Strafella AP
    Brain; 2014 Aug; 137(Pt 8):2143-54. PubMed ID: 24736308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
    Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
    Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis.
    Mihaescu AS; Masellis M; Graff-Guerrero A; Kim J; Criaud M; Cho SS; Ghadery C; Valli M; Strafella AP
    Brain Imaging Behav; 2019 Aug; 13(4):1021-1034. PubMed ID: 29971686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of insula in Parkinson's disease: A quantitative meta-analysis study.
    Criaud M; Christopher L; Boulinguez P; Ballanger B; Lang AE; Cho SS; Houle S; Strafella AP
    Hum Brain Mapp; 2016 Apr; 37(4):1375-92. PubMed ID: 26800238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease.
    Chen CH; Lee BC; Lin CH
    J Parkinsons Dis; 2020; 10(1):77-88. PubMed ID: 31868681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson's disease.
    Madhyastha TM; Askren MK; Zhang J; Leverenz JB; Montine TJ; Grabowski TJ
    Brain; 2015 Sep; 138(Pt 9):2672-86. PubMed ID: 26173859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
    Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
    Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease, cortical dysfunction, and alpha-synuclein.
    Caviness JN; Lue LF; Beach TG; Hentz JG; Adler CH; Sue L; Sadeghi R; Driver-Dunckley E; Evidente VG; Sabbagh MN; Shill HA; Walker DG
    Mov Disord; 2011 Jul; 26(8):1436-42. PubMed ID: 21542019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
    Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
    Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease.
    Schulz J; Pagano G; Fernández Bonfante JA; Wilson H; Politis M
    Brain; 2018 May; 141(5):1501-1516. PubMed ID: 29701787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing an aetiological model of visual hallucinations in Parkinson's disease.
    Gallagher DA; Parkkinen L; O'Sullivan SS; Spratt A; Shah A; Davey CC; Bremner FD; Revesz T; Williams DR; Lees AJ; Schrag A
    Brain; 2011 Nov; 134(Pt 11):3299-309. PubMed ID: 21921019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis.
    Wolters AF; van de Weijer SCF; Leentjens AFG; Duits AA; Jacobs HIL; Kuijf ML
    Parkinsonism Relat Disord; 2019 May; 62():16-27. PubMed ID: 30580907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional segregation of basal ganglia pathways in Parkinson's disease.
    Neumann WJ; Schroll H; de Almeida Marcelino AL; Horn A; Ewert S; Irmen F; Krause P; Schneider GH; Hamker F; Kühn AA
    Brain; 2018 Sep; 141(9):2655-2669. PubMed ID: 30084974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal features of β-γ phase-amplitude coupling in Parkinson's disease derived from scalp EEG.
    Gong R; Wegscheider M; Mühlberg C; Gast R; Fricke C; Rumpf JJ; Nikulin VV; Knösche TR; Classen J
    Brain; 2021 Mar; 144(2):487-503. PubMed ID: 33257940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical disinhibition in Parkinson's disease.
    Ammann C; Dileone M; Pagge C; Catanzaro V; Mata-Marín D; Hernández-Fernández F; Monje MHG; Sánchez-Ferro Á; Fernández-Rodríguez B; Gasca-Salas C; Máñez-Miró JU; Martínez-Fernández R; Vela-Desojo L; Alonso-Frech F; Oliviero A; Obeso JA; Foffani G
    Brain; 2020 Dec; 143(11):3408-3421. PubMed ID: 33141146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.
    Fathy YY; Jonker AJ; Oudejans E; de Jong FJJ; van Dam AW; Rozemuller AJM; van de Berg WDJ
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):262-277. PubMed ID: 29797340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for adaptive cortical changes in swallowing in Parkinson's disease.
    Suntrup S; Teismann I; Bejer J; Suttrup I; Winkels M; Mehler D; Pantev C; Dziewas R; Warnecke T
    Brain; 2013 Mar; 136(Pt 3):726-38. PubMed ID: 23412935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RBD: a red flag for cognitive impairment in Parkinson's disease?
    Lin YQ; Chen SD
    Sleep Med; 2018 Apr; 44():38-44. PubMed ID: 29530367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.